Milltrust International Group
Venture capitalLondon · Seed–Late Stage · 22 people tracked
Find your way into Milltrust International Group
Sign up to see every warm intro you have to Milltrust International Group
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Milltrust International Group team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Milltrust invests around a 'One Health' philosophy that seeks to align personal wealth creation with the well-being of the planet, food systems, and people. Through its asset management arm it builds multi-asset and emerging-markets strategies, while Milltrust Ventures makes private investments in long-term secular themes spanning food, health, and planet. The group also invests in sustainable agriculture, managing tens of thousands of hectares of cultivated land. It emphasises sustainable, ethical, and forward-looking investments as a signatory to the UN Principles for Responsible Investment, targeting themes such as the development of emerging economies, rising food demand, technological change, and climate change.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curatedAlexander Kalis is a Strategic Adviser to Milltrust International Group and East West Private Wealth, and a Board Director of Milltrust International Investments SPC. He co-founded Milltrust International and served as Group Managing Partner, leading venture capital investments in food, health, and climate technologies and acting as Portfolio Manager for the British Innovation Fund I & II and the MAI farmland funds. Earlier he held senior roles at Edmond de Rothschild Asset Management and Santander Asset Management, founded Think Alternative Advisors LLP, and holds a Master's in Management from the Université Catholique de Louvain.
Simon Hopkins has worked in international investment management for over three decades, beginning at S.G. Warburg and UBS and holding senior roles at HSBC James Capel and Nomura. He founded the alternatives investment advisory Fortune Group, later acquired by Close Brothers Group, and in 2010 established Milltrust International in Singapore, focusing on emerging markets, agricultural investments, and science and technology innovation. He previously served as an investment manager at CerraCap Ventures and holds a law degree from the University of Bristol.
Eric Anderson is Head of Global Wealth Solutions & Global Emerging Markets at Milltrust International LLP, where he contributes to the firm's global asset allocation models, its Emerging Markets Platform, and the Milltrust Global Emerging Markets Fund. He has more than two decades of international investment industry experience across the US, Europe, and Asia. He previously was Managing Partner at Think Alternative Advisors LLP (acquired by Milltrust in 2010) and held roles at Credit Suisse, Ortus Capital Management, and State Street Global Advisors. He holds a degree in International Economics from the University of California, Berkeley.
Gary Dugan is an investment professional with 38 years of experience across Europe, the Middle East, and Asia. He began his career in London and joined JPMorgan Securities in 1993 as a European equity market strategist, later becoming head of multi-asset portfolios at JPMorgan Asset Management, and has held CIO roles at Barclays and Merrill Lynch. He is currently CIO at East West Private Wealth, having previously served as CEO of Purple Asset Management and founded The Global CIO Office, which provides outsourced CIO services.
Dr Milla Marinova worked as a medical doctor for over eight years and holds an M.Sc. in International Health Policy from LSE and an M.Phil. in Bioscience Enterprise from Cambridge University. She has held roles including Honorary Research Fellow at Imperial College London and external consultant to McKinsey, and has worked with the Royal College of Physicians of Edinburgh in partnership with the WHO on healthcare quality governance. She was a principal at GrayBella Capital, a growth-capital VC investing in European health companies, and founded R8ER, a digital evaluation platform for healthcare.
Protap Mukherjee is Senior Managing Director and Head of GCC/Asia at East West Private Wealth, based in the UAE, with more than 26 years in financial services. His prior roles include Executive Director at Schroders in Singapore, Senior Director at DBS Bank, and Director positions at BNP Paribas Wealth Management and Falcon Private Bank, along with earlier posts at First Abu Dhabi Bank and Standard Chartered Bank. He holds a Business Management degree from the Indian Institute of Management, Calcutta, and is a Chartered Wealth Manager accredited by the American Academy of Financial Management.
Cecilia McLaughlin is a Portfolio Manager at Milltrust International LLP, having begun her financial career in 1995 at institutions including Goldman Sachs, Citibank, and Alliance Investment Bank. She has experience across equities and multiple asset classes, along with multi-asset dealing and execution. At Milltrust she manages international high net worth clients and works on business development, client relationship management, and investment management.
Henry Soediarko is Senior Portfolio Manager and Head of Research for the Climate Impact Asia Fund, based in Singapore. He has over 12 years of experience in the Asian equity long/short hedge fund industry, having held roles in portfolio management, trading, and risk management at firms including Creo Capital, Hachiman Capital, and Amoeba Capital, and was previously an Asian equity analyst at Smartkarma where he incorporated ESG analysis into his research. He holds an MBA from Vlerick Business School in Belgium and an MSc in Investment from City University Business School in England.
Sean Ang is a Director of Milltrust Ventures, the private markets arm of Milltrust International Group, working on early-stage investments and venture-building. He previously served as Business Lead of the NUS Institute for Functional Intelligent Materials (I-FIM), where he focused on commercializing advanced materials technology through IP licensing and academic spin-offs, and earlier worked as a management consultant at DayDayUp Global. He holds a Bachelor of Engineering (Honors) from the National University of Singapore with a double major in Biomedical Engineering and Innovation & Design (Entrepreneurship).
Senior Adviser at East West Private Wealth.
Dr Bernard Ng works in medical and clinical affairs across global, regional, and local levels in the pharmaceutical and consumer health industry. He previously served as Vice President, Head of Global Medical & Clinical Affairs for Bayer Consumer Healthcare, and advocates for using digital technologies and data in healthcare. He holds a Doctor of Medicine from the National University of Malaysia and an MBA from the University of Melbourne.
Devangana Yadav is Head of Operations at East West Private Wealth in Singapore, with over nine years in banking and financial services focused on client servicing for HNI/UHNI segments. She has worked in relationship management, transaction execution, operations, and KYC/compliance, previously serving as an Associate Vice President at Trica in Mumbai and Assistant Vice President in Wealth Management at BNP Paribas, and beginning her career at ICICI Bank. She holds an MBA in Marketing and a Graduate Diploma in Foreign Trade from the University of Pune and a BBA from the University of Nagpur.
Diana The has over 25 years of experience across the legal and financial services industries, including nearly 17 years as in-house Chief Counsel spanning Asia-Pacific, the Middle East, and Africa at institutions such as Harmony Capital Partners, Eastspring Investments, Aon, and the digital banking group Tyme. She holds an LLB (Hons) from the University of Bristol and was called to the English and Singapore bars, and later earned an Executive MBA at Nanyang Business School. She focuses on funds, financial services, family offices, and fintechs, and runs her own law firm, THE Legal Concierge LLC.
Edward Higgins is Chief Operating Officer and Senior Relationship Manager at East West Private Wealth, having previously worked at Julius Baer in Singapore serving UK and international clients. Over more than two decades he has held roles at Julius Baer Singapore, Credit Suisse Singapore, and spent nearly nine years as a Wealth Manager at Morgan Stanley in the UK, working with ultra-high-net-worth clients. He focuses on investments, hedge funds, and corporate finance, is a graduate of the University of Newcastle-upon-Tyne, and trained as an ACA with Menzies LLP.
Gary Thornton is Head of Finance & Operations and a co-founder of Milltrust International Group, where he oversees finance, fund and company operations, legal, HR, and the compliance and risk functions for the Climate Impact Asia Fund. He holds directorships across several Milltrust entities and is a partner of Milltrust International LLP. Before Milltrust, he audited Fortune Group at HW Fisher, later served as Fortune's finance director, and headed finance and operations for the institutional team at Close Asset Management; he qualified as a chartered accountant with Moore Stephens in 1993 and holds a Master's degree from Trinity Hall, Cambridge.
Jenalyn Modesto is an Associate at Milltrust International Group. She previously held roles including Retail Marketing Intern at Citibank N.A., Executive Secretary in the Product and Market Development Unit at BDO Unibank, Sales and Finance Manager at her family's rice retail business J. Modesto Store, and Business Development Intern at SmartBite Singapore, a B2B food tech company. She holds a Bachelor of Science in Business Administration from Asia Pacific College and is completing an MBA at Singapore Management University in March 2025 as an Ayala Postgraduate Scholarship recipient.
Johann Henn is Chief Executive Officer at Alternative Investment Partners (AIP) in South Africa. He previously co-founded Novare Holdings, where he served as Chief Executive Officer and later as Executive Deputy Chairman from August 2014, focusing on strategic client relationships and company growth. He began his career at Sanlam Asset Management in 1994 as a Senior Fund Manager.
Mark Ebert is Chairman of Milltrust International Managed Investments ICAV, with over three decades of experience across investment banking, equity brokerage, private equity, and asset management. He qualified as a Certified Public Accountant at Price Waterhouse and later worked at Citicorp Scrimgeour Vickers and UBS, where he became Head of Mergers & Acquisitions; he was co-head of Panmure Gordon and helped found its private equity business (now Lyceum Capital), and oversaw investment banking at Lombard Odier & Cie. He holds a PhD from the Royal Agricultural University.
Sonia Malik is Senior Vice President at East West Private Wealth, with over two decades of experience in private banking serving high-net-worth and ultra-high-net-worth clients across Canada, the Middle East, and Asia. She previously held senior leadership roles at CIBC Private Wealth in Canada. Her work focuses on private wealth advisory, family office structuring, and cross-border investment solutions. She holds an MBA in Finance from École Nationale des Ponts et Chaussées and a Bachelor of Commerce from the University of Lucknow, and holds PFP, CSC, and CPH certifications.
William Mendes is a Senior Relationship Manager at East West Private Wealth with a background in financial services spanning business development, client relationship management, and wealth management. He previously worked as a Business Development Executive at FTFT Capital Investments LLC covering cryptocurrency, blockchain, and fintech, and held roles at Commercial Bank of Dubai, L&T Capital Markets, RAKBANK, HSBC, and American Express Services India. He holds an International Certificate in Wealth Management from the Securities and Investment Institute in London and an AMFI Certification from India.
Mikael Hed is a co-founder of Rovio and served as its CEO. He returned to the company in 2009 during a period of financial difficulty and helped lead the development of Angry Birds, contributing his comics background to the game's branding and narrative and refining its game mechanics.
Uttkarsh Sogani is a Senior Associate on the investments team at InnoVen Capital India, a venture debt fund, where he focuses on consumer and fintech investments. He has over seven years of experience in investment banking and equity research, holds a Bachelor's degree in Financial Markets from H.R. College of Commerce and Economics, and earned the CFA Charter in February 2022.
Founder mafia
2 people who came through Milltrust International Group went on to found or lead other companies.
What they invest in
from 15 of 18 portfolio companiesBiotech ×8Deep Tech ×6Digital Health ×5Medical Devices ×5AI & Machine Learning ×4AgTech ×3Cleantech ×3Climate Tech ×2
HQs:United Kingdom×10United States×1
Investments · 18 tracked
founders shown can be your intro pathBarinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific immunotherapies designed to guide T cells to treat autoimmune and inflammatory diseases.
BiotechDeep TechHealthtechMedical Devices
Geoffrey Lynn(Chief Scientific Officer)inWilliam Enright(Chief Executive Officer & Board Director)Leon Hooftman(Chief Medical Officer)inBill EnrightinAdrian Hill(Founder)Sarah Gilbert(Founder)
Co-investorsFuture Planet CapitalGV (Google Ventures)Oxford Science EnterprisesGilead SciencesKorea Investment PartnersTencent Holdings+1 more
52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.
BiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsMeridian Health VenturesCambridge Angels groupFuture Planet CapitalParkwalk AdvisorsSie VenturesCambridge Innovation Capital+2 more
AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma.
BiotechDigital HealthMedical DevicesNewcastle upon Tyne, GB
Penny Lovat(Chief Scientific Officer)in
Co-investorsConduit ConnectEsperante VenturesFuture Planet CapitalNorthstar Ventures
Attomarker develops rapid diagnostic technologies using nanophotonic testing for healthcare applications.
AI & Machine LearningBiotechDeep TechDigital HealthMedical Devices
Andrew Shaw(CEO & Founder)in
Co-investorsFuture Planet Capital
CORE POWER develops nuclear energy solutions designed for deployment in hard-to-decarbonize industries that require reliable, continuous power.
CleantechClimate TechDeep TechEnergyLondon, GB
Mikal Bøe(Founder)in
Co-investorsMOL SwitchNucleation Capital
A wealth management and private capital advisory firm providing asset management, portfolio management, and strategic financial services for high-net-worth clients and institutional investors.
Enterprise SoftwareFintechLondon, GB
Simon Hopkins(Founder & Chairman)inAlexander Kalis(Founder & Strategic Adviser)inGary Thornton(Founder & Group Head of Finance & Operations)in
Eupnoos is a diagnostics company that turns smartphones into a clinical-grade screening tool, using acoustic biomarkers and explainable AI to differentiate airway obstruction from heart failure in under 60 seconds.
AI & Machine LearningDigital HealthMedical Devices
Arshia Gratiot(CEO)Dr. Deepak Kotak(CMO)Antonius Schneider(CSO)Dr. Yordan Raykov(CTO)
Oxford Science Enterprises is a venture-building investment firm, working in partnership with the University of Oxford, that funds and creates companies based on scientific research from Oxford, Harwell and Culham.
BiotechDeep TechQuantum ComputingOxford, GB
Co-investorsOxfordOxford University Innovation
Polymateria develops a proprietary plastic additive formulation that enables conventional plastics to biodegrade fully in natural environments without harming recycling streams.
BiotechCircular EconomyCleantechClimate TechNew Materials
Richard Hornein
Co-investorsBridford Investments (Bridford Group)Giant LeapPeak Sustainability VenturesThe CraftoryTemasek
Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.
CleantechDeep TechHardwareSemiconductorsCambridge, GB
Co-investorsCambridge Innovation CapitalIn-Q-TelProsperity7 VenturesARMBritish Patient CapitalCatalyst+4 more
Roslin Technologies develops and supplies animal stem cells for cultivated meat production, enabling producers to reach market faster and reduce costs.
AgTechBiotechFoodTech
Ernst Van Orsouw(CEO)
Co-investorsKickstart Ventures
Shandi Global makes a range of plant-based, high-protein food products, including burger patties, schnitzels, nuggets, protein chunks, soups, and flavored protein drinks.
AgTechConsumerFoodTechWellness & FitnessSingapore</anq_city>
Dr. Gaurav Sharma(Co-Founder, CEO)
Co-investorsBrinc
Viome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations.
AI & Machine LearningDigital HealthDirect to ConsumerLongevityWellness & FitnessBellevue, US
Naveen Jain(Founder)inGuruduth Banavar(Founding CTO & Head of Discovery AI)inMomo Vuyisich(Founding CSO & Head of Clinical Research)inDEEPAK SAVADATTI(Executive Officer)inStephen Barrie(VP & Head of Clinical Nutrition)inShannon Pappas(President, Consumer Business)in
Co-investorsBold Capital PartnersEastward Capital PartnersPHD VenturesSquareOne CapitalWestRiver GroupKhosla Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bugera BioOncoshot
Exits · 1
1 IPOsBarinthusbioNASDAQ: BRNS
Portfolio news
latest coverage across their companiesEast West Private Wealth · altss.com · Jun 3, 2026
Frequently asked questions
- How many investments has Milltrust International Group made?
- Milltrust International Group has 18 tracked investments, 1 of which have exited.
- What stage does Milltrust International Group invest at?
- Milltrust International Group invests at the Seed, Late Stage stages.
- What is Milltrust International Group's typical check size?
- Milltrust International Group typically writes checks of $2.5M.
- What sectors does Milltrust International Group focus on?
- Milltrust International Group focuses on AgTech, AI & Machine Learning, Cleantech, Climate Tech, Deep Tech, FoodTech, Healthtech, Impact & Social Good.
- Where is Milltrust International Group located?
- Milltrust International Group is headquartered in London, GB.
- Does Milltrust International Group lead rounds?
- Yes, Milltrust International Group leads investment rounds.
Media · Podcasts & interviews
featuring the teamSALT Voices: Simon Hopkins | Chief Executive Officer, Milltrust International Group
SALT · Simon Hopkins
Market Update #52: Oil, inflation and a bond market losing patience | #EWPW #Milltrust #EricAnderson
Milltrust International
Market Update #51: Markets caught between weaker employment and persistent inflation | #EWPW
Milltrust International
Market Update #50: When the Tech Growth Story Meets the Bond Market | #EWPW #EricAnderson #Milltrust
Milltrust International
Market Update #47: Proof, Not Promises | #EWPW #Milltrust #GlobalMarkets
Milltrust International
Market Update #49: The Price of Money | #EWPW #Milltrust #GlobalMarkets #EastWestPrivateWealth
Milltrust International
Images
Similar investors
The Ireland Strategic Investment Fund (ISIF) is a sovereign development fund managed and controlled by Ireland's National Treasury Management Agency, mandated to invest on a commercial basis to support economic activity and employment in Ireland.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Emerald Technology Ventures is a venture capital investor focused on complex, cutting-edge technologies, supporting entrepreneurs at the frontier of scientific and industrial innovation.
INP Capital is a global investment firm that invests across the full company life cycle, from early stage to pre-IPO, seeking to identify and back emerging technology companies as they scale toward unicorn status.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.

































































